Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3
Go back to Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 70.34 -1.48 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.82 | 52 Week High | $8.22 | |||
| Open | $70.92 | 52 Week Low | $3.07 | |||
| Day High | $73.00 | P/E | N/A | |||
| Day Low | $69.95 | EPS | $-1.30 | |||
| Volume | 1,361,221 | |||||
